Our data tentatively suggests that combination strategies to break down tumor microenvironmental signals might be a strategy to overcome PD‐1 resistance, indeed re‐invigoration of exhausted T‐cells is an active area of investigation [32]. The gene discussed is PDCD1; the disease is neoplasm.